| 臺大學術典藏 |
2021-09-27T06:18:43Z |
Bevacizumab dose affects the severity of adverse events in gynecologic malignancies
|
Lee S.-P.; HENG-CHENG HSU; Tai Y.-J.; Chen Y.-L.; Chiang Y.-C.; Chen C.-A.; Cheng W.-F. |
| 國立臺灣大學 |
2009 |
Bevacizumab for the Treatment of Corneal Neovascularization
|
陳偉勵; 陳彥名; 朱筱桑; 蔡紫筠; 胡芳蓉; CHEN, WEI-LI; CHEN, YAN-MING; CHU, HSIAO-SANG; TSAI, TZU-YUN; HU, FUNG-RONG |
| 臺大學術典藏 |
2020-10-22T07:41:52Z |
Bevacizumab for the treatment of corneal neovascularization
|
Hu F.-R.; Lin Y.-H.; Tsai T.-Y.; Chu H.-S.; Chen Y.-M.; WEI-LI CHEN |
| 臺大學術典藏 |
2022-07-15T08:17:47Z |
Bevacizumab for the treatment of corneal neovascularization
|
Chen W.-L.; Chen Y.-M.; Chu H.-S.; Lin Y.-H.; Tsai T.-Y.; FUNG-RONG HU |
| 臺大學術典藏 |
2020-05-26T09:26:21Z |
Bevacizumab in EGFR-positive NSCLC: time to change first-line treatment?
|
Chih-Hsin Yang; CHIH-HSIN YANG |
| 國立臺灣大學 |
2009 |
Bevacizumab Is Not Toxic to Retinal Ganglion Cells after Repeated Intravitreal Injection
|
鄭成國; 彭百慧; 田履黛; 陳朝峰; 李憶菁; CHENG, CHENG-KUO; PENG, PAI-HUEI; TIEN, LU-TAI; CHEN, CHAU-FONG; LEE, YIH-JING |
| 國立臺灣大學 |
2016 |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen, I-Chun; Lin, Ching-Hung; Jan, I-Shiow; Cheng, Ann-Lii; Lu, Yen-Shen; 盧彥伸; 林璟宏; 詹一秀; 陳怡君; 鄭安理; 林季宏 |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen;林季宏; Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen; Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen; 盧彥伸;林璟宏;詹一秀;陳怡君;鄭安理;林季宏; I-SHIOW JAN; Kao, Jia-Horng; Chen, I-Chun; Lin, Ching-Hung; CHING-HUNG LIN; Lin, Ching-Hung; ANN-LII CHENG; Jan, I-Shiow; Jan, I-Shiow; Cheng, Ann-Lii; Cheng, Ann-Lii; Lu, Yen-Shen; Lu, Yen-Shen; 高嘉宏 |
| 臺大學術典藏 |
2020-05-25T06:51:50Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen I.-C;Lin C.-H;Jan I.-S;Cheng A.-L;Yen-Shen Lu; Chen I.-C; Lin C.-H; Jan I.-S; Cheng A.-L; YEN-SHEN LU |
| 臺大學術典藏 |
2021-03-12T00:50:54Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen I.-C.; Lin C.-H.; I-SHIOW JAN; Cheng A.-L.; Lu Y.-S. |
